Profile
Karen Lowe is currently the Director-Finance & Director at Oxford Cannabinoid Technologies Ltd. and a Member at the Association of Certified Fraud Examiners.
She previously worked as a Non-Executive Director at Oxford Cannabinoid Technologies Holdings Plc in 2022.
Ms. Lowe completed her undergraduate degree at Leeds Beckett University and Bremen University of Applied Sciences.
Karen Lowe active positions
| Companies | Position | Start |
|---|---|---|
Association of Certified Fraud Examiners
Association of Certified Fraud Examiners Miscellaneous Commercial ServicesCommercial Services Provides anti-fraud training and educational services | Corporate Officer/Principal | - |
Oxford Cannabinoid Technologies Ltd.
Oxford Cannabinoid Technologies Ltd. Pharmaceuticals: OtherHealth Technology Engages in researching, developing and licensing cannabinoid-based compounds and therapies | Director of Finance/CFO | - |
Former positions of Karen Lowe
| Companies | Position | End |
|---|---|---|
| OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | Director of Finance/CFO | 26/08/2022 |
Training of Karen Lowe
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Leeds Beckett University
Leeds Beckett University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Association of Certified Fraud Examiners
Association of Certified Fraud Examiners Miscellaneous Commercial ServicesCommercial Services Provides anti-fraud training and educational services | Commercial Services |
Bremen University of Applied Sciences
Bremen University of Applied Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford Cannabinoid Technologies Ltd.
Oxford Cannabinoid Technologies Ltd. Pharmaceuticals: OtherHealth Technology Engages in researching, developing and licensing cannabinoid-based compounds and therapies | Health Technology |
Oxford Cannabinoid Technologies Holdings Plc
Oxford Cannabinoid Technologies Holdings Plc Pharmaceuticals: MajorHealth Technology Provides cannabinoid drug development services | Health Technology |
- Stock Market
- Insiders
- Karen Lowe
















